January 13, 2022 03:20 PM EST
Marketing

#JPM22: The fire­side chat with Take­da CEO Christophe We­ber

John Carroll

Editor & Founder

John Car­roll:

Okay every­body. This is John Car­roll. I am back with Christophe We­ber, the CEO of Take­da. We had a chance to talk I …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

WuXi com­pa­nies may sell units im­pact­ed by Biose­cure — re­port

Biotech's third quar­ter was rel­a­tive­ly bright — with a few caveats

EMA re­views hair loss prod­ucts fol­low­ing con­cerns about sui­ci­dal thoughts

Af­ter $14B ex­it, Karuna co-founder finds next bet; Ex-Re­genxbio CEO Ken Mills heads to Tag­works

Sanofi sells rare dis­ease drug En­jay­mo to Recor­dati for $825M up­front

sponsored

3 Tiers for AAV Po­ten­cy As­say De­vel­op­ment Suc­cess

A service from the Financial Times